SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new development or finding in product specification without further noticed.
Nome Químico: Sodium 2-((1R,8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-1-sulfo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl phosphate
Shipping Temperature: Ambient
HSN Code: 38229010
Country of Origin: India
Sorrisos: O=P([O-])([O-])OCC([C@@]1(O)[C@H](C)C[C@@]2([H])[C@]3([H])CCC4=CC(C[C@@H](S(=O)(O)=O)[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)=O)=O.[Na+].[Na+]
Dexamethasone Sodium Phosphate Impurity 5 is chemically Sodium 2-((1R,8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-1-sulfo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl phosphate. Dexamethasone Sodium Phosphate Impurity 5 is supplied with detailed characterization data compliant with regulatory guideline. Dexamethasone Sodium Phosphate Impurity 5 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dexamethasone sodium phosphate.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Stability and compatibility of methotrexate and dexamethasone in 0.9% sodium chloride for intrathecal injection
By Xu, Fan; Zeng, Su
From Pakistan Journal of Pharmaceutical Sciences (2020), 33(6), 2477-2481
Method development and validation for simultaneous estimation of ofloxacin and dexamethasone sodium phosphate by RP-HPLC
By Renukadevi, G. N.; Lakshmi, M. Sri; Prathyusha, V.; Sharmila, S. K.; Kumari, K. Shantha
From World Journal of Pharmaceutical Research (2014), 3(Suppl.5), 369-381
Simultaneous estimation of moxifloxacin hydrochloride and dexamethasone sodium phosphate in bulk and in ophthalmic solution by RP-HPLC
By Dhumal, D. M.; Shirkhedkar, A. A.; Nerkar, P. P.; Surana, S. J.
From Journal of the Chilean Chemical Society (2012), 57(4), 1344-1347